Nostics is pioneering a diagnostic platform that leverages advanced technologies such as Raman spectroscopy, nanotechnology, and artificial intelligence (AI) to facilitate rapid pathogen identification at the point-of-care. This innovative approach allows healthcare providers to obtain reliable diagnostic results in less than 15 minutes, enabling them to prescribe the appropriate antibiotics during the initial patient consultation. By providing actionable insights directly at the point of care, Nostics aims to enhance treatment efficacy, reduce complications from ineffective therapies, and combat the growing issue of antimicrobial resistance.

The versatility of Nostics' platform is designed to detect a wide range of pathogens from various sample sources, making it suitable for diverse healthcare settings, including primary care facilities and hospitals. The integration of these cutting-edge technologies not only improves the accuracy and accessibility of diagnostics but also addresses the critical need for timely information in the treatment of bacterial infections. By focusing on affordability and ease of use, Nostics is committed to transforming the landscape of infectious disease diagnostics, ultimately improving health outcomes for patients worldwide.

Netherlands

By applying nanotechnology, photonics and machine learning, Nostics brings a new type of diagnostics to a world desperately in need for 21st century solutions. 

We believe that a good life starts with good health. We believe that accessible and affordable diagnostics should be a given for our entire human family. Improvements in healthcare can only start when we know what’s going on. By providing instant and affordable testing at any location, Nostics wants to contribute to a better safer and healthier world.

Nostics

Company Details